Novartis Pharma AG provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, NOV offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. NOV Group companies employ approximately 123,000 associates (2015) and operate in more than 140 countries around the world. The NOV strategy is to deliver better outcomes for patients through science-based innovation. In line with this overall objective, NOV strive for the highest business standards across their entire enterprise, including preclinical research, in which we have considerable experience of implementing phase appropriate Quality systems. NOV participation in the EQIPD and other IMI / EFPIA consortium initiatives help contribute real world evidence to future decision making in health care systems.